Alaunos Therapeutics | ZIOP - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Amgen USD 6.89B 415M 2025-12
AstraZeneca USD 12.61B 225M 2026-03
Baxter International USD 891M 314M 2026-03
Biogen USD 1.82B 169.5M 2026-03
Bioline Rx USD 343K 111K 2025-09
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Celltrion KRW 46.98B 579.12B 2025-12
Corcept Therapeutics USD 162.02M 37.56M 2026-03
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Curis USD 1.14M 8.86M 2025-12
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 16.59B 2.05B 2025-12
Gilead Sciences USD 5.52B 791M 2026-03
GlaxoSmithKline GBP 5.75B 429M 2026-03
Incyte USD 1.17B 217.51M 2026-03
Intrexon USD -297K 167K 2024-06
Ionis Pharmaceuticals USD 243M 48M 2026-03
J&J USD 17.24B 642M 2026-03
Kangmei Pharma CNY 270.29M 20.26M 2025-09
Karyopharm Therapeutics USD 32.6M 63.38M 2025-12
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Medical Developments International AUD 7.35M 7.37M 2025-06
Merck USD 10.85B 2.57B 2025-12
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Novartis USD 10.07B 184M 2026-03
Organigram Holdings CAD 23.32M 8.52M 2025-12
Pfizer USD 11.04B 1.24B 2026-03
Pharma Mar EUR 39.24M 47.46M 2026-03
PTC Therapeutics USD 232.94M 84.56M 2026-03
Qiagen NV USD 325.27M 19.53M 2025-12
Regeneron Pharmaceuticals USD 2.94B 363.7M 2026-03
Roche Holding CHF 22.09B 10.04B 2025-12
Sangamo BioSciences -2.39M 1.09M 2024-06
Sartorius EUR 414.5M 18.3M 2026-03
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
TG Therapeutics USD 171.41M 16.98M 2026-03
Tilray USD 57.47M 10.16M 2025-06
Verastem USD 14.64M 14.1M 2025-12
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zz Pientze Pharmaceu CNY 1.16B 860.2M 2026-03